| Tag | Content |
|---|
EnhancerAtlas ID | HS139-20577 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr16:23915940-23917100 |
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10888 | chr16:23911613-23916113 | CD20 | | SE_10888 | chr16:23916310-23922828 | CD20 | | SE_40183 | chr16:23916271-23917642 | K562 | | SE_67999 | chr16:23846983-23921777 | TC32 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH16I023898 | chr16 | 23909650 | 23917121 |
|
Enhancer Sequence | ACTACTGCAC TCCAGCCTGG GTGACAGAGC GAGTCTTCAT CTCAAAAGAA CAACAACAAC 60
AACAACAAAA AACCACAACA CTTAGAAGAG TATCTAGCAT ATAGTAAGTG CTTCAGTGCT 120
TTATACATGT CAGTTATTGG TAGTACTCAA AATATTTGGG ATTTAAAAGT TGGGGGATTT 180
TTACATAAAA GGCACTTTTC CTCTTTGAGT GGTAAAATCT CCCCTAAGAA AGAGGCAAGG 240
ACAGATGGAG ATGATCTGAG AGGCCCAAGA GATCCTTAAA ACCAGGCTTT TTAAGAAATC 300
TGATGTTTTA TTTCTCCGTA TTGTCATGGA AAAGGCCAGC TTTTAGCATG CCTGGTGTTT 360
CTGGTGTTTT CTTCTCTTCA CTGTTTTCTA CATTTCTTTC TTTGCATTGG TCCTTTTTTT 420
TTCTTTTTTT TTTTTTTAAT AAAAAAAAAA TAGCACAGCT CGGAGTCTTG CTTGCTGACT 480
TACTGCTAGA GTGTGGGATC CATTGCTTCC ATTTAGAGAA GCAGCCGGCC CTGGAATGTG 540
GCCGCAGGGC TGCCAGGCTG ACTCTGTGAG CTGAGCTGGC GAGGAATGCA CTTTGCAGCT 600
TGCACTGAGT TTGGCCTTAC GTCTGTGGAA TTTCTTCTCT CTTCTTACTC ATTCGTGTCG 660
TTAAATAAAT AACAACACAA GCAGTGCATC CTCCCGGTTA TAATGGCAAA CAGTACAATG 720
TGTTACAACA CACAGTAGCT TGAAGAGGAT ATCTCTCTCC TGTGGTAGAT GCTTCATTCC 780
CCAGAACTTC ACTCCTCACC CCCAGAATAG GTTGCCCAGT TAACAGGATG CCTGGTTCAG 840
TCTGCATTTT GGGTAAACAA GGAACACCTT TTTAGTATAA GTATGTCCCA AATATTGCAT 900
AGCACCAACT TATCCTAAAA CACTATTTGT TGTTTATGTG CTATTCAGGT TTAACTGGGC 960
ATTCTGTAGT TTTATTTGCT AAATCTGACA ACTCCAGAGA GTCTCCTAGA ACCAGTTTCC 1020
TGTATTTTCT TCCAGTAATT TTCCAAGCAT GTGCAACCTA TGGATATCTT GGCAGACTTA 1080
CTCCTGGTAG AATTCCCATC ACCTAGAACA GTGCTTAGGA CATTGTAGGT GCTTAATAAA 1140
TATGGGTTGA ATGAGTGATT 1160
|
